Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma

Completed · Phase 2

Conditions studied: Healthy, Mycobacterium Infections, Atypical

In brief

This is an open label study to determine the effects of the administration of Interferon-gamma on the clinical condition and immune function of patients with severe, treatment refractory non-tuberculosis mycobacterial infections. The study drug (interferon gamma) will be administered subcutaneously three times a week at 0.05 mg/m(2) for one year. We may also collect blood from the relatives of these patients and normal volunteers in order to characterize the genetic basis, if any, of our patients' disorders.

Key facts

Study ID
NCT00001318
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
60
Starts
1992-08-01
Expected to finish
2000-11-01
Last updated by the study team
2008-03-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.